S&P/ASX 200 Index (ASX: XJO) shares are in the red today, down 1.35% to 7,349 points.
However, a number of stocks have reached 52-week highs, and most of them are tech shares.
The S&P/ASX 200 Information Technology Index (ASX: XIJ) is the only market sector in the green today.
Let's take a look at today's star ASX 200 shares.
Image source: Getty Images
Which ASX 200 shares are creating price records today?
WiseTech Global Ltd (ASX: WTC)
ASX 200 tech giant WiseTech reached a new 52-week high of $87.41 today. This logistics software company continues to attract investors due to the popularity of its products. Its CargoWise One platform delivered revenue growth of 50% in the first half of FY23. As the largest of the tech shares on the ASX, Wisetech has also benefitted from a rally in overseas and Australian tech shares since early 2023.
Worley Ltd (ASX: WOR)
This ASX 200 industrial share has reset its 52-week high once again, reaching $17.55 today. The engineering company does a lot of consultancy work with major miners and appears to be riding a wave of cautious optimism in the resources sector in light of China's intention to stimulate its economy.
Nextdc Ltd (ASX: NXT)
Data centre operator NextDC is another ASX 200 share hitting a 52-week high today at $13.23. Top broker Goldman Sachs thinks NextDC will benefit from the structural shift to the cloud and artificial intelligence (AI). The broker has a buy rating on NextDC and a 12-month price target of $14.96.
CSR Limited (ASX: CSR)
The ASX 200 building materials share reached a 52-week high of $5.82 today. CSR shares have had a strong consistent run since the company released its full-year results in May. CSR delivered a 17% increase in net profit after tax (NPAT) for the year ended 31 March, up 17% on the previous year.
Aristocrat Leisure Limited (ASX: ALL)
The Aristocrat share price has been steadily rising all year, up 31% in the year to date. The ASX 200 gaming tech share hit a new 52-week high of $40.38 today. Macquarie has an outperform rating on Aristocrat with a 12-month share price target of $46.50. Morgans has an add rating and a $45 price target.
Pro Medicus Limited (ASX: PME)
The Pro Medicus share price reached a new annual high of $71.60 today. The ASX 200 medical tech share began a strong run northwards in mid-June 2022 and has added 39% to its valuation since. Goldman Sachs recently upgraded its rating to buy with an improved share price target of $76.
